Frontline Immunotherapy Combined With Radiation and Chemotherapy in High Risk Endometrial Cancer

NCT03932409 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Endometrial Cancer

Interventions

DRUG: Pembrolizumab
RADIATION: Vaginal cuff brachytherapy (VCB)
DRUG: Paclitaxel
DRUG: Carboplatin

Sponsor

University of Oklahoma

Collaborators

[object Object]